Literature DB >> 29761310

Characteristics of patients with a relatively greater minimum VE/VCO2 against peak VO2% and impaired exercise tolerance.

Taisuke Nakade1, Hitoshi Adachi2, Makoto Murata3, Shigeru Oshima2.   

Abstract

PURPOSE: Cardiopulmonary exercise testing (CPX) is used to evaluate functional capacity and assess prognosis in cardiac patients. Ventilatory efficiency (VE/VCO2) reflects ventilation-perfusion mismatch; the minimum VE/VCO2 value (minVE/VCO2) is representative of pulmonary arterial blood flow in individuals without pulmonary disease. Usually, minVE/VCO2 has a strong relationship with the peak oxygen uptake (VO2), but dissociation can occur. Therefore, we investigated the relationship between minVE/VCO2 and predicted peak VO2 (peak VO2%) and evaluated the parameters associated with a discrepancy between these two parameters.
METHODS: A total of 289 Japanese patients underwent CPX using a cycle ergometer with ramp protocols between 2013 and 2014. Among these, 174 patients with a peak VO2% lower than 70% were enrolled. Patients were divided into groups based on their minVE/VCO2 [Low group: minVE/VCO2 < mean - SD (38.8-5.6); High group: minVE/VCO2 > mean + SD (38.8 + 5.6)]. The characteristics and cardiac function at rest, evaluated using echocardiography, were compared between groups.
RESULTS: The High group had a significantly lower ejection fraction, stroke volume, and cardiac output, and higher brain natriuretic peptide, tricuspid regurgitation pressure gradient, right ventricular systolic pressure, and peak early diastolic LV filling velocity/peak atrial filling velocity ratio compared with the Low group (p's < 0.01). In addition, the Low group had a significantly higher prevalence of pleural effusion than did the High group (26 vs 11%, p < 0.01).
CONCLUSIONS: Patients with a relatively greater minVE/VCO2 in comparison with peak VO2 had impaired cardiac output as well as restricted pulmonary blood flow increase during exercise, partly due to accumulated pleural effusion.

Entities:  

Keywords:  Cardiac output; Cardiopulmonary exercise test; Peak VO2; min VE/VCO2

Mesh:

Year:  2018        PMID: 29761310     DOI: 10.1007/s00421-018-3884-1

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  20 in total

1.  Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2).

Authors:  D P Francis; W Shamim; L C Davies; M F Piepoli; P Ponikowski; S D Anker; A J Coats
Journal:  Eur Heart J       Date:  2000-01       Impact factor: 29.983

2.  Usefulness of mitral annular velocity in predicting exercise tolerance in patients with impaired left ventricular systolic function.

Authors:  Yasuyuki Hadano; Kazuya Murata; Takeshi Yamamoto; Hideki Kunichika; Tomo Matsumoto; Eizo Akagawa; Takashi Sato; Takeo Tanaka; Yoshio Nose; Nobuaki Tanaka; Masunori Matsuzaki
Journal:  Am J Cardiol       Date:  2006-02-17       Impact factor: 2.778

3.  Assessment of functional capacity in clinical and research settings: a scientific statement from the American Heart Association Committee on Exercise, Rehabilitation, and Prevention of the Council on Clinical Cardiology and the Council on Cardiovascular Nursing.

Authors:  Ross Arena; Jonathan Myers; Mark A Williams; Martha Gulati; Paul Kligfield; Gary J Balady; Eileen Collins; Gerald Fletcher
Journal:  Circulation       Date:  2007-06-18       Impact factor: 29.690

4.  Wasting as independent risk factor for mortality in chronic heart failure.

Authors:  S D Anker; P Ponikowski; S Varney; T P Chua; A L Clark; K M Webb-Peploe; D Harrington; W J Kox; P A Poole-Wilson; A J Coats
Journal:  Lancet       Date:  1997-04-12       Impact factor: 79.321

5.  An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry.

Authors:  Gregg C Fonarow; Preethi Srikanthan; Maria Rosa Costanzo; Guillermo B Cintron; Margarita Lopatin
Journal:  Am Heart J       Date:  2007-01       Impact factor: 4.749

6.  Cardiopulmonary exercise testing variables reflect the degree of diastolic dysfunction in patients with heart failure-normal ejection fraction.

Authors:  Marco Guazzi; Jonathan Myers; Mary Ann Peberdy; Daniel Bensimhon; Paul Chase; Ross Arena
Journal:  J Cardiopulm Rehabil Prev       Date:  2010 May-Jun       Impact factor: 2.081

Review 7.  Cardiopulmonary Exercise Test.

Authors:  Hitoshi Adachi
Journal:  Int Heart J       Date:  2017-09-30       Impact factor: 1.862

8.  Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction.

Authors:  Barry A Borlaug; Rick A Nishimura; Paul Sorajja; Carolyn S P Lam; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2010-06-11       Impact factor: 8.790

9.  Optimizing the exercise protocol for cardiopulmonary assessment.

Authors:  M J Buchfuhrer; J E Hansen; T E Robinson; D Y Sue; K Wasserman; B J Whipp
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-11

10.  Superior vena caval pressure elevation causes pleural effusion formation in sheep.

Authors:  S J Allen; G A Laine; R E Drake; J C Gabel
Journal:  Am J Physiol       Date:  1988-09
View more
  1 in total

1.  Microvasculopathy Evaluated by Dual-Energy Computed Tomography in Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension.

Authors:  Keisuke Miwa; Yu Taniguchi; Hiroyuki Fujii; Yoichiro Matsuoka; Hiroyuki Onishi; Kenichi Yanaka; Yu Izawa; Yasunori Tsuboi; Atsushi Kono; Noriaki Emoto; Kenichi Hirata
Journal:  Life (Basel)       Date:  2022-08-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.